Schizophrenia associated sensory gating deficits develop after adolescent microglia activation

Brain, Behavior, and Immunity

Volumn 58, Issue , 2016, Pages 99-106

  Eßlinger, Manuela ^a,b   Wachholz, Simone ^a,b   Manitz, Marie Pierre ^a,b   Plümper, Jennifer ^a,b   Sommer, Rainer ^a   Juckel, Georg ^a,b   Friebe, Astrid ^a,b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Animal model; M1; M2; Microglia; Poly(I:C); PPI; Schizophrenia

Indexed keywords

B7 ANTIGEN; CD200 RECEPTOR; CD40 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CX3CR1; GLYCOPROTEIN P 15095; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYINOSINIC POLYCYTIDYLIC ACID; TUMOR NECROSIS FACTOR; CYTOKINE; POLYCYTIDYLIC ACID;

ADULTHOOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CELL ACTIVATION; CELL POLARITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IMMUNOCOMPETENT CELL; MALE; MICROGLIA; MOUSE; NONHUMAN; PERINATAL INFECTION; PREPULSE INHIBITION; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PUBERTY; RISK FACTOR; SCHIZOPHRENIA; SENSORY GATING; SEX DIFFERENCE; STARTLE REFLEX; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; IMMUNOLOGY; METABOLISM; PREGNANCY; PRENATAL EXPOSURE; PSYCHOLOGY;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE, INBRED BALB C; MICROGLIA; POLY C; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SENSORY GATING;

EID: 84971612085     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.05.018     Document Type: Article

References (50)

1. Aloisi, F., Immune function of microglia. Glia 36 (2001), 165–179.
2. Arai, S., Takuma, K., Mizoguchi, H., Ibi, D., Nagai, T., Takahashi, K., et al. Involvement of pallidotegmental neurons in methamphetamine- and MK-801-induced impairment of prepulse inhibition of the acoustic startle reflex in mice: reversal by GABAB receptor agonist baclofen. Neuropsychopharmacology 33 (2008), 3164–3175.
3. Biswas, S.K., Mantovani, A., Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11 (2010), 889–896.
4. Bowdish, D.M.E., Loffredo, M.S., Mukhopadhyay, S., Mantovani, A., Gordon, S., Macrophage receptors implicated in the “adaptive” form of innate immunity. Microbes Infect. 9 (2007), 1680–1687.
5. Brown, A.S., Begg, M.D., Gravenstein, S., Schaefer, C.A., Wyatt, R.J., Bresnahan, M., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 61 (2004), 774–780.
6. Brown, A.S., Schaefer, C.A., Quesenberry, C.P., Liu, L., Babulas, V.P., Susser, E.S., Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am. J. Psychiatry 162 (2005), 767–773.
7. Campanella, M., Sciorati, C., Tarozzo, G., Beltramo, M., Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke 33 (2002), 586–592.
8. Cardona, A.E., Pioro, E.P., Sasse, M.E., Kostenko, V., Cardona, S.M., Dijkstra, I.M., et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9 (2006), 917–924.
9. Chhor, V., Le Charpentier, T., Lebon, S., Oré, M., Celador, I.L., Josserand, J., et al. Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav. Immun. 32 (2013), 70–85.
10. Chu, H.X., Arumugam, T.V., Gelderblom, M., Magnus, T., Drummond, G.R., Sobey, C.G., Role of CCR2 in inflammatory conditions of the central nervous system. J. Cereb. Blood Flow Metab. 34 (2014), 1425–1429.
11. Cromwell, H.C., Mears, R.P., Whan, L., Boutros, N.N., Sensory gating: a translational effort from basic to clinical science. Clin. EEG Neurosci., 2008, 69–72.
12. de Simone, R., Giampaolo, A., Giometto, B., Gallo, P., Levi, G., Peschle, C., et al. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J. Neuropathol. Exp. Neurol. 54 (1995), 175–187.
13. Dijkstra, I.M., de Haas, A.H., Brouwer, N., Boddeke, H.W.G.M., Biber, K., Challenge with innate and protein antigens induces CCR7 expression by microglia in vitro and in vivo. Glia 54 (2006), 861–872.
14. Durafourt, B.A., Moore, C.S., Zammit, D.A., Johnson, T.A., Zaguia, F., Guiot, M., et al. Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia 60 (2012), 717–727.
15. Fatemi, S.H., Reutiman, T.J., Folsom, T.D., Huang, H., Oishi, K., Mori, S., et al. Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr. Res. 99 (2008), 56–70.
16. Fife, B.T., Huffnagle, G.B., Kuziel, W.A., Karpus, W.J., CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 192 (2000), 899–905.
17. Gadani, S.P, Cronk, J.C, Norris, G.T, Kipnis, J., IL-4 in the brain: a cytokine to remember. J. Immunol. 189 (2012), 4213–4219.
18. Gaupp, S., Pitt, D., Kuziel, W.A., Cannella, B., Raine, C.S., Experimental autoimmune encephalomyelitis (EAE) in CCR2(−/−) mice: susceptibility in multiple strains. Am. J. Pathol. 162 (2003), 139–150.
19. Harrison, J.K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R.K., et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Neurobiology, 1998, 10896–10901.
20. Hu, X., Leak, R.K., Shi, Y., Suenaga, J., Gao, Y., Zheng, P., et al. Microglial and macrophage polarization—new prospects for brain repair. Nat. Rev. Neurol. 11 (2015), 56–64.
21. Ibi, D., Nagai, T., Kitahara, Y., Mizoguchi, H., Koike, H., Shiraki, A., et al. Neonatal polyI: C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood. Neurosci. Res. 64 (2009), 297–305.
22. Immig, K., Gericke, M., Menzel, F., Merz, F., Krueger, M., Schiefenhövel, F., et al. CD11c-positive cells from brain, spleen, lung, and liver exhibit site-specific immune phenotypes and plastically adapt to new environments. Glia 63 (2015), 611–625.
23. Izikson, L., Klein, R.S., Luster, A.D., Weiner, H.L., Targeting monocyte recruitment in CNS autoimmune disease. Clin. Immunol. (Orlando, Fla.) 103 (2002), 125–131.
24. Juckel, G., Manitz, M.P., Brüne, M., Friebe, A., Heneka, M.T., Wolf, R.J., Microglial activation in a neuroinflammational animal model of schizophrenia – a pilot study. Schizophr. Res. 131 (2011), 96–100.
25. Koning, N., Swaab, D.F., Hoek, R.M., Huitinga, I., Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions. J. Neuropathol. Exp. Neurol. 68 (2009), 159–167.
26. Maio, M., Del Vecchio, L., Expression and functional role of CD54/Intercellular Adhesion Molecule-1 (ICAM-1) on human blood cells. Leuk. Lymphoma 8 (1992), 23–33.
27. Manitz, M.P., Esslinger, M., Wachholz, S., Plümper, J., Friebe, A., Juckel, G., et al. The role of microglia during life span in neuropsychiatric disease – an animal study. Schizophr. Res. 143 (2013), 221–222.
28. Mantovani, A., From phagocyte diversity and activation to probiotics: back to Metchnikoff. Eur. J. Immunol. 38 (2008), 3269–3273.
29. Mednick, S.A., Machon, R.A., Huttunen, M.O., Bonett, D., Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch. Gen. Psychiatry 45 (1988), 189–192.
30. Meyer, U., Feldon, J., To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology 62 (2012), 1308–1321.
31. Meyer, U., Feldon, J., Schedlowski, M., Yee, B.K., Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci. Biobehav. Rev. 29 (2005), 913–947.
32. Meyer, U., Feldon, J., Schedlowski, M., Yee, B.K., Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav. Immun. 20 (2006), 378–388.
33. Meyer, U., Nyffeler, M., Schwendener, S., Knuesel, I., Yee, B.K., Feldon, J., Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 33 (2008), 441–456.
34. Mortensen, P.B., Nørgaard-Pedersen, B., Waltoft, B.L., Sørensen, T.L., Hougaard, D., Torrey, E.F., et al. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol. Psychiatry 61 (2007), 688–693.
35. Ozawa, K., Hashimoto, K., Kishimoto, T., Shimizu, E., Ishikura, H., Iyo, M., Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol. Psychiatry 59 (2006), 546–554.
36. Paolicelli, R.C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., et al. Synaptic pruning by microglia is necessary for normal brain development. Science (New York, N.Y.) 333 (2011), 1456–1458.
37. Paylor, R., Crawley, J.N., Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology 132 (1997), 169–180.
38. Peferoen, L.A.M., Vogel, D.Y.M., Ummenthum, K.B., Breur, M.B., Heijnen, P.D.B., Gerritsen, W.H.B., et al. Activation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosis. J. Neuropathol. Exp. Neurol., 2015, 48–63.
39. Piontkewitz, Y., Assaf, Y., Weiner, I., Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia. Biol. Psychiatry 66 (2009), 1038–1046.
40. Radewicz, K., Garey, L., Gentleman, S., Reynolds, R., Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J. Neuropathol. Exp. Neurol. 59 (2000), 137–150.
41. Schaefer, M., Capuron, L., Friebe, A., Diez-Quevedo, C., Robaeys, G., Neri, S., et al. Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement. J. Hepatol. 57 (2012), 1379–1390.
42. Sheridan, G.K., Murphy, K.J., Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage. Open Biol., 3, 2013, 130181.
43. Shi, L., Fatemi, S.H., Sidwell, R.W., Patterson, P.H., Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci., 2003, 297–302.
44. Sørensen, H.J., Mortensen, E.L., Reinisch, J.M., Mednick, S.A., Association between prenatal exposure to bacterial infection and risk of schizophrenia. Schizophr. Bull. 35 (2009), 631–637.
45. Tundup, S., Srivastava, L., Harn, D.A., Polarization of host immune responses by helminth-expressed glycans. Ann. N. Y. Acad. Sci. 1253 (2012), E1–E13.
46. van Rossum, D., Hanisch, U., Microglia. Metab. Brain Dis. 19 (2004), 393–411.
47. Weinberger, D.R., Schizophrenia as a neurodevelopmental disorder. Hirsch, S.T., Weinberger, D.R., (eds.) Schizophrenia, 1995, Blackwell Science, Oxford, 293–323.
48. Wollenberg, A., Mommaas, M., Oppel, T., Schottdorf, E., Günther, S., Moderer, M., Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases. J. Invest. Dermatol., 2002.
49. Zabel, M.K., Kirsch, W.M., From development to dysfunction: microglia and the complement cascade in CNS homeostasis. Ageing Res. Rev. 12 (2013), 749–756.
50. Zhu, F., Zheng, Y., Liu, Y., Zhang, X., Zhao, J., Minocycline alleviates behavioral deficits and inhibits microglial activation in the offspring of pregnant mice after administration of polyriboinosinic-polyribocytidilic acid. Psychiatry Res. 219 (2014), 680–686.